Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial.

Research output: Contribution to journalConference abstract in journalResearch

  • N Finer
  • M. Al Hakim
  • Astrup, Arne
  • A Harper
  • M Lean
  • L Niskanen
  • M.F. Rasmussen
  • A. Rissanen
  • S Rössner
  • L Van Gaal
Original languageEnglish
JournalDiabetologia
Volume52
Issue numberSuppl. 1
Pages (from-to)S11-S12
Number of pages2
ISSN0012-186X
Publication statusPublished - 2009
EventAnnual Meeting of the European Association for the Study of Diabetes - Wien, Austria
Duration: 29 Sep 20092 Oct 2009
Conference number: 45

Conference

ConferenceAnnual Meeting of the European Association for the Study of Diabetes
Number45
CountryAustria
CityWien
Period29/09/200902/10/2009

ID: 17518971